Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
about
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative statesThe Role of Chemokines in Promoting Colorectal Cancer Invasion/MetastasisZinc finger protein 451 is a novel Smad corepressor in transforming growth factor-β signalingPathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling?Smad4-expression is decreased in breast cancer tissues: a retrospective study.MicroRNA-192 suppresses liver metastasis of colon cancer.Allelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment.Deletion and down-regulation of SMAD4 gene in colorectal cancers in a Chinese population.A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer.The role of SMAD4 in early-onset colorectal cancerImmunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray studyIdentification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II).Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cellsTumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancerPrognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.Debate about TGFBR1 and the susceptibility to colorectal cancerSmad4 deficiency in cervical carcinoma cells.Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.Role of phytochemicals in the inhibition of epithelial-mesenchymal transition in cancer metastasis.Smad4 inactivation promotes malignancy and drug resistance of colon cancer.Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis.Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells.Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells.TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis.Smad4 haploinsufficiency: a matter of dosage.miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis.High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis.Loss of heterozygosity on chromosome 10p14-p15 in colorectal carcinoma.Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer
P2860
Q21260380-917947CA-9119-423E-B9E2-8C9318C8DD11Q26748194-651091AE-A7D4-4405-8159-25694537F6F1Q28115541-E86DC22C-D499-4071-99EB-51F19A53EBCEQ28237728-200560A0-315C-4A0C-9272-A48EEFDB4285Q33232550-E388488C-5144-42A6-8F39-6E06E76275F7Q33594662-E3C601ED-2D9C-4E06-9417-43E1322B7E43Q33721457-86051BDB-67DD-4AAE-9FFC-F48639DFB277Q34452747-7475C2DB-AA8E-442A-9EAE-C465AD9B54FCQ35150637-22479103-4473-476D-9E9D-06248764A989Q35587027-FBEBD6CB-770B-4132-B7C1-92A9D464798FQ35587209-57523B29-2F68-4E8F-9D80-1C20622C4654Q35608709-85B0E488-11E5-4813-B8CD-5E55075C4625Q35608989-FF7CFBB6-4667-44AF-A350-FA8DE26BD7CAQ35969342-8F8B2EA7-2D81-446C-B23B-81F83AFF78C0Q36288636-8687B180-4370-4DAC-8CD6-F98906DCD695Q36348635-E864C1F1-95DD-44C2-8E85-6EA3C081C7EBQ37341673-13673FAA-0A41-4AD5-83E9-D746D032BF16Q37586913-3E04FBFA-86B5-498D-929C-4DB550116041Q37746284-9C73182A-722E-4994-9F36-A93BE234C63FQ37985996-81A9D764-469E-460B-A2D7-CCDF6A94E145Q38334502-5A536EE0-BC6A-40E8-9706-133F10FC5F2CQ38680776-1DE57C54-FBED-443F-AF5F-87BFFCE9FA23Q38923272-E3962D0B-8B77-4978-820A-00CCBA47FDB4Q39606293-ADB2CE2C-0413-401D-B607-6D1325131CA0Q39630626-B1667E32-A977-431B-A857-7A059C4E895CQ40211704-A59DFA28-F713-435D-9806-BE2ABA55BF9BQ40473801-96685A69-8518-4806-8B9C-B2A9410FFA07Q41636916-18AE083F-68BA-459C-8A81-8F7F990A8B92Q41994842-9D051110-7EEF-4392-94C1-4AFBB9BB4D0DQ46556476-E07F653E-0D86-4BE6-BA25-52AD423E3C42Q47758650-32B8479D-4AF5-4008-AFED-58924B0103B4Q53215560-7F91F578-C9BD-4E9C-BF6F-3D8FD2CA2E8EQ54646579-67AB69C9-51F1-49F3-952C-454303E00CD6Q54680362-E0F89743-D811-4689-ACEE-035E1C119486Q58051474-7D3DE698-CABE-40EC-BF80-ADDAA56764D1
P2860
Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
@en
type
label
Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
@en
prefLabel
Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
@en
P2093
P2860
P356
P1433
P1476
Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
@en
P2093
E Avizienyte
H Järvinen
M Sarlomo-Rikala
P Sistonen
R Salovaara
S Souchelnytskyi
V Launonen
P2860
P356
10.1136/GUT.51.1.56
P407
P577
2002-07-01T00:00:00Z